Literature DB >> 3498747

Duodenal mucosal injury with nonsteroidal antiinflammatory drugs.

R Eliakim1, M Ophir, D Rachmilewitz.   

Abstract

The effect of nonsteroidal antiinflammatory drugs (NSAIDs) on duodenal mucosa was assessed both retrospectively and prospectively. In 444 patients with duodenal ulcer, the incidence of upper gastrointestinal bleeding was five times higher in 56 patients who were treated with NSAIDs than in those who did not receive NSAIDs. Indomethacin and naproxen had the most potent damaging effects. In a control group of patients with gastric ulcer, nine out of 134 had taken NSAIDs. The incidence of bleeding in these patients was three times higher than in those who were not on NSAIDs. The effect of indomethacin, 150 mg/day, on the upper gastrointestinal tract was examined in a prospective study of 75 patients with acute musculoskeletal disorders. Endoscopy after 1 week of therapy showed that 45% had mucosal damage in the duodenum, and this was as frequent and as severe as the gastric mucosal damage. In most instances, the duodenal damage was erosive duodenitis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3498747     DOI: 10.1097/00004836-198708000-00008

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  7 in total

1.  Cimetidine decreases indomethacin induced duodenal mucosal damage in patients with acute musculoskeletal disorders.

Authors:  R Stalnikowicz; D Pollak; A Eliakim; D Wengrower; A Fich; E Goldin; M Ligumsky; D Rachmilewitz
Journal:  Gut       Date:  1988-11       Impact factor: 23.059

2.  FFA2 activation combined with ulcerogenic COX inhibition induces duodenal mucosal injury via the 5-HT pathway in rats.

Authors:  Yasutada Akiba; Koji Maruta; Kazuyuki Narimatsu; Hyder Said; Izumi Kaji; Ayaka Kuri; Ken-Ichi Iwamoto; Atsukazu Kuwahara; Jonathan D Kaunitz
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-05-19       Impact factor: 4.052

Review 3.  Naproxen. A reappraisal of its pharmacology, and therapeutic use in rheumatic diseases and pain states.

Authors:  P A Todd; S P Clissold
Journal:  Drugs       Date:  1990-07       Impact factor: 9.546

4.  Cyclooxygenase inhibition with indomethacin increases human duodenal mucosal response to prostaglandin E1.

Authors:  D L Hogan; M A Ballesteros; M A Koss; J I Isenberg
Journal:  Dig Dis Sci       Date:  1989-12       Impact factor: 3.199

Review 5.  Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach.

Authors:  F Richy; O Bruyere; O Ethgen; V Rabenda; G Bouvenot; M Audran; G Herrero-Beaumont; A Moore; R Eliakim; M Haim; J-Y Reginster
Journal:  Ann Rheum Dis       Date:  2004-07       Impact factor: 19.103

6.  Risk of acute upper gastrointestinal bleeding in patients with ulcerative disease and treatment with non-steroidal anti-inflammatory drugs (NSAIDs). Results from the Comprehensive Hospital Drug Monitoring Berne (CHDM).

Authors:  E Stodolnik; P Maurer; R Hoigné; T Hess; U Müller; F Amonn; F Halter; R Maibach; U P Künzi
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

7.  Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine.

Authors:  R S Ehsanullah; M C Page; G Tildesley; J R Wood
Journal:  BMJ       Date:  1988-10-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.